These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 24417376)
1. Absolute beat-to-beat variability and instability parameters of ECG intervals: biomarkers for predicting ischaemia-induced ventricular fibrillation. Sarusi A; Rárosi F; Szűcs M; Csík N; Farkas AS; Papp JG; Varró A; Forster T; Curtis MJ; Farkas A Br J Pharmacol; 2014 Apr; 171(7):1772-82. PubMed ID: 24417376 [TBL] [Abstract][Full Text] [Related]
2. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs). Lu HR; Yan GX; Gallacher DJ J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247 [TBL] [Abstract][Full Text] [Related]
3. Development and characterization of a mouse in vitro model of ischaemia-induced ventricular fibrillation. Stables CL; Curtis MJ Cardiovasc Res; 2009 Jul; 83(2):397-404. PubMed ID: 19228704 [TBL] [Abstract][Full Text] [Related]
4. The isolated blood-perfused rat heart: an inappropriate model for the study of ischaemia- and infarction-related ventricular fibrillation. Clements-Jewery H; Hearse DJ; Curtis MJ Br J Pharmacol; 2002 Dec; 137(7):1089-99. PubMed ID: 12429582 [TBL] [Abstract][Full Text] [Related]
5. Biomarkers and endogenous determinants of dofetilide-induced torsades de pointes in α(1) -adrenoceptor-stimulated, anaesthetized rabbits. Farkas AS; Rudas L; Makra P; Csík N; Leprán I; Forster T; Csanády M; Papp JG; Varró A; Farkas A Br J Pharmacol; 2010 Dec; 161(7):1477-95. PubMed ID: 20659107 [TBL] [Abstract][Full Text] [Related]
6. An increasing electromechanical window is a predictive marker of ventricular fibrillation in anesthetized rabbit with ischemic heart. Limprasutr V; Pirintr P; Kijtawornrat A; Hamlin RL Exp Anim; 2018 May; 67(2):175-183. PubMed ID: 29162767 [TBL] [Abstract][Full Text] [Related]
7. Assessment of efficacy of proarrhythmia biomarkers in isolated rabbit hearts with attenuated repolarization reserve. Orosz S; Sarusi A; Csík N; Papp JG; Varró A; Farkas S; Forster T; Farkas AS; Farkas A J Cardiovasc Pharmacol; 2014 Sep; 64(3):266-76. PubMed ID: 24887684 [TBL] [Abstract][Full Text] [Related]
8. Electrocardiographic parameters effectively predict ventricular tachycardia/fibrillation in acute phase and abnormal cardiac function in chronic phase of ST-segment elevation myocardial infarction. Yu Z; Chen Z; Wu Y; Chen R; Li M; Chen X; Qin S; Liang Y; Su Y; Ge J J Cardiovasc Electrophysiol; 2018 May; 29(5):756-766. PubMed ID: 29399929 [TBL] [Abstract][Full Text] [Related]
9. Regional beat-to-beat variability of repolarization increases during ischemia and predicts imminent arrhythmias in a pig model of myocardial infarction. Amoni M; Ingelaere S; Moeyersons J; Wets D; Tanushi A; Van Huffel S; Varon C; Sipido K; Claus P; Willems R Am J Physiol Heart Circ Physiol; 2023 Jul; 325(1):H54-H65. PubMed ID: 37145956 [TBL] [Abstract][Full Text] [Related]
10. Utility of the JT Peak Interval and the JT Area in Determining the Proarrhythmic Potential of QT-Shortening Agents. Qiu B; Wang Y; Li C; Guo H; Xu Y J Cardiovasc Pharmacol Ther; 2019 Mar; 24(2):160-171. PubMed ID: 30092655 [TBL] [Abstract][Full Text] [Related]
12. Susceptibility to ischemia-induced ventricular fibrillation in isolated female rat hearts varies moderately with estrous cycle stage. Hatcher AS; Clements-Jewery H J Pharmacol Toxicol Methods; 2013; 67(3):134-9. PubMed ID: 23357189 [TBL] [Abstract][Full Text] [Related]
13. Feasibility of targeting ischaemia-related ventricular arrhythmias by mimicry of endogenous protection by endocannabinoids. Andrag E; Curtis MJ Br J Pharmacol; 2013 Aug; 169(8):1840-8. PubMed ID: 23713981 [TBL] [Abstract][Full Text] [Related]
14. Electrocardiographic Parameters Indicating Worse Evolution in Patients with Acquired Long QT Syndrome and Torsades de Pointes. Kukla P; Jastrzębski M; Fijorek K; Stec S; Bryniarski L; Czarnecka D; Baranchuk A Ann Noninvasive Electrocardiol; 2016 Nov; 21(6):572-579. PubMed ID: 27018992 [TBL] [Abstract][Full Text] [Related]
15. Disturbances of cardiac wavelength and repolarization precede Torsade de Pointes and ventricular fibrillation in Langendorff perfused rabbit hearts. Hondeghem LM Prog Biophys Mol Biol; 2016 May; 121(1):3-10. PubMed ID: 26980523 [TBL] [Abstract][Full Text] [Related]
16. The effects of endothelin-1 on ischaemia-induced ventricular arrhythmias in rat isolated hearts. Sharif I; Crockett TR; Kane KA; Wainwright CL Eur J Pharmacol; 2001 Sep; 427(3):235-42. PubMed ID: 11567654 [TBL] [Abstract][Full Text] [Related]
17. Review of the predictive value of the Langendorff heart model (Screenit system) in assessing the proarrhythmic potential of drugs. Valentin JP; Hoffmann P; De Clerck F; Hammond TG; Hondeghem L J Pharmacol Toxicol Methods; 2004; 49(3):171-81. PubMed ID: 15172013 [TBL] [Abstract][Full Text] [Related]
18. Selective heart rate reduction with ivabradine slows ischaemia-induced electrophysiological changes and reduces ischaemia-reperfusion-induced ventricular arrhythmias. Ng FS; Shadi IT; Peters NS; Lyon AR J Mol Cell Cardiol; 2013 Jun; 59():67-75. PubMed ID: 23402927 [TBL] [Abstract][Full Text] [Related]
19. Inadequate ischaemia-selectivity limits the antiarrhythmic efficacy of mibefradil during regional ischaemia and reperfusion in the rat isolated perfused heart. Farkas A; Qureshi A; Curtis MJ Br J Pharmacol; 1999 Sep; 128(1):41-50. PubMed ID: 10498833 [TBL] [Abstract][Full Text] [Related]
20. New in vitro model for proarrhythmia safety screening: IKs inhibition potentiates the QTc prolonging effect of IKr inhibitors in isolated guinea pig hearts. Kui P; Orosz S; Takács H; Sarusi A; Csík N; Rárosi F; Csekő C; Varró A; Papp JG; Forster T; Farkas AS; Farkas A J Pharmacol Toxicol Methods; 2016; 80():26-34. PubMed ID: 27063345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]